| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,754 |
23,224 |
$2.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,656 |
20,047 |
$2.13M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,167 |
10,964 |
$1.05M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,660 |
10,427 |
$998K |
| S9083 |
Global fee urgent care centers |
8,908 |
7,416 |
$931K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,820 |
3,422 |
$351K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,900 |
2,889 |
$261K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,050 |
13,793 |
$53K |
| 99215 |
Prolong outpt/office vis |
216 |
210 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
411 |
358 |
$16K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,583 |
5,283 |
$9K |
| 99205 |
Prolong outpt/office vis |
100 |
98 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,182 |
7,884 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,359 |
4,598 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
1,168 |
1,125 |
$944.96 |
| 87428 |
|
149 |
142 |
$635.90 |
| 73610 |
|
524 |
506 |
$428.95 |
| 81025 |
|
2,426 |
2,329 |
$420.86 |
| 73630 |
|
593 |
572 |
$418.36 |
| 36415 |
Collection of venous blood by venipuncture |
1,575 |
1,503 |
$369.01 |
| 0012A |
|
14 |
14 |
$360.00 |
| 81003 |
|
4,290 |
4,076 |
$352.59 |
| 73562 |
|
189 |
182 |
$208.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
400 |
354 |
$119.64 |
| 73110 |
|
68 |
66 |
$92.25 |
| 73130 |
|
31 |
29 |
$92.25 |
| 73140 |
|
50 |
50 |
$92.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
25 |
12 |
$92.25 |
| 93000 |
|
579 |
563 |
$88.67 |
| 73120 |
|
45 |
45 |
$78.00 |
| 69209 |
|
93 |
92 |
$40.00 |
| 99000 |
|
14,056 |
13,029 |
$27.18 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
224 |
203 |
$13.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
58 |
$13.36 |
| 87807 |
|
161 |
157 |
$11.68 |
| 86308 |
|
55 |
51 |
$3.00 |
| 73030 |
|
39 |
39 |
$0.00 |
| 99173 |
|
145 |
129 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
13 |
13 |
$0.00 |
| 82947 |
|
18 |
15 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
29 |
28 |
$0.00 |
| 82962 |
|
25 |
25 |
$0.00 |